Skip to main content

Advertisement

SpringerLink
Log in

Donor minipool NAT screening for HBV, HCV, and HIV: a 2-year experience in a private hospital in Saudi Arabia

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Blood transfusion is a life-saving approach, although it carries the risk of transfusion-transmitted viruses (TTVs). In Saudi Arabia (SA), nucleic acid amplification test (NAT) has been obligatory for HCV, HBV, and HIV by 2008. Our aim is to evaluate the effectiveness of NAT for detection of TTVs in the blood donated at Saudi German Hospitals (SGH) in SA. A total of 12,437 donor samples from SGH between January 2009 and June 2011 were subjected to routine serologic tests for HBV, HCV, and HIV followed by minipool NAT using Cobas Amplicor analyzer (Roche Diagnostics) for the seronegative samples. Out of 12,032 seronegative plasmas, five (0.042 %) were positive for HCV and two (0.017 %) for HIV-1 by NAT. None of our seronegative donors were NAT positive for HBV, highlighting the value of hepatitis B core antibody detection in donor testing. Our results provide evidence to support the effectiveness of NAT screening to detect TTVs in blood donations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abdel Gader AM, Osman AA, Al Gahtani FH et al (2011) Attitude to blood donation in Saudi Arabia. Asian J Transfus Sci 5:121–126

    Article  PubMed Central  PubMed  Google Scholar 

  • Akhter J, Roberts GT, Perry A, Julie SG, Howman PA (2001) Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population. Saudi Med J 22(12):1073–1075

    CAS  PubMed  Google Scholar 

  • Alswaidi FM, O'Brien SJ (2009) Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: review and factors affecting their success. J Med Screen 16(1):22–28

    Article  PubMed  Google Scholar 

  • Alswaidi FM, O'Brien SJ (2010) Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? J Epid & Com Health 64:989–997

    Article  CAS  Google Scholar 

  • Ashshi AM (2012) Detection of occult hepatitis B virus in anti-HBc positive/anti-HBs positive blood donors in Saudi Arabia. Res J Med Sci 6(2):61–65

    Google Scholar 

  • Bamaga MS, Bokhari FF, Aboud AM et al (2006) Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations. Saudi Med J 27(6):781–787

    PubMed  Google Scholar 

  • Biswas R, Tabor E, Hsia CC et al (2003) Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43:788–798

    Article  PubMed  Google Scholar 

  • Busch MP, Glynn S, Stramer S, Strong DM, Caglioti S et al (2005) A new strategy for estimating risks of transfusion transmitted viral infections based on rates of infection of recently infected donors. Transfusion 45:254–264

    Article  PubMed  Google Scholar 

  • Candotti D, El Chaar M, Allain J (2011) Transfusion transmission of hepatitis B virus: still learning more about it. ISBT Sci Ser 6:234–240

    Article  Google Scholar 

  • Center for Biologics Evaluation and Research (2009) Blood Products Advisory Committee, 94th meeting. Gaithersburg, April 1

  • Comanor L, Holland P (2006) Hepatitis B virus blood screening: unfinished agendas. Vox Sang 91:1–12

    Article  CAS  PubMed  Google Scholar 

  • Dodd R, Notari E, Stramer S (2002) Current prevalence and incidence of infectious disease markers and estimated WP risk in the American Red Cross blood donor population. Transfusion 42:975–979

    Article  CAS  PubMed  Google Scholar 

  • Duong Ly T, Laperche S, Brennan C et al (2004) Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods 122:185–194

    Article  Google Scholar 

  • Dwyre DM, Holland PV (2008) Hepatitis viruses. In: Barbara JAJ, Regan FAM, Contreras MC (eds) Transfusion microbiology. Cambridge University Press, Cambridge, pp 9–23

    Chapter  Google Scholar 

  • Dwyre DM, Fernando LP, Holland PV (2011) Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 100:92–98

    Article  CAS  PubMed  Google Scholar 

  • El Chaar M, Candotti D, Crowther RA et al (2010) Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600–1610

    Article  PubMed  Google Scholar 

  • El-Hazmi M (2004) Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Med J 25:26–33

    PubMed  Google Scholar 

  • Gerlich WH, Bremer C, Saniewski M, SchĂĽttler CG, Wend UC et al (2010) Occult hepatitis B virus infection: detection and significance. Dig Dis 28:116–125

    Article  PubMed  Google Scholar 

  • Gonçales TT, Sabino EC, Salles NA et al (2009) HIV testing and confidential unit exclusion users in São Paulo. Brazil Transf 49(3):4A

    Google Scholar 

  • Hajeer AH, Al Gharawi K, Al Rayes W et al (2008) Detection of HCV antibody-negative donations: Saudi experience with nucleic acid testing. British J Biomed Sci 65(2):103–104

    CAS  Google Scholar 

  • Harritshoj LH, Dickmeiss E, Hansen MB et al (2008) Transfusion-transmitted HIV infection by a Danish blood donor with a very low viral load in the preseroconversion window phase. Transfusion 48:2026–2028

    PubMed  Google Scholar 

  • Kapoor D, Saxena R, Sood B, Sarin SK (2000) Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol 19:64–67

    CAS  PubMed  Google Scholar 

  • Kleinman SH, Busch MP (2006) Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Vir 36(1):S23–S29

    Article  Google Scholar 

  • Kleinman SH, Strong DM, Tegtmeier G et al (2005) Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 45:1247–1257

    Article  CAS  PubMed  Google Scholar 

  • Kretzschmar E, Chudy M, Nuebling CM et al (2007) First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays. Vox Sang 92:297–301

    CAS  PubMed  Google Scholar 

  • Kuliya-Gwarzo A (2011) Screening for blood transfusion transmissible viruses in resource limited settings. The Internet J of Infectious Dis; 9(1). doi: 10.5580/132e

  • Laperche S (2005) Blood safety and nucleic acid testing in Europe. Euro Surveill 10(2):3–4

    CAS  PubMed  Google Scholar 

  • Makroo RN, Choudary N, Jagannathan L et al (2008) Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Ind J Med Res 127:140–147

    CAS  Google Scholar 

  • Melve GK, Myrmel H, Eide GE et al (2009) Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion 49:2359–2365

    Article  PubMed  Google Scholar 

  • Nübling CM, Heiden M, Chudy M, Kress J et al (2009) Experience of mandatory NAT screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 49:1850–1858

    Article  PubMed  Google Scholar 

  • Phelps R, Robbins K, Liberti T et al (2004) Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 44:929–933

    Article  PubMed  Google Scholar 

  • Quresh M, Mohammed AS, Malik S (2007) Seroprevalence of HBsAg, HCV and HIV antibodies in healthy individuals in Makkah region, KSA. Biomedica 23:12–16

    Google Scholar 

  • Raghuraman S, Subramaniam T, Daniel D et al (2003) Occurrence of false positives during testing for antibodies to HCV among volunteer blood donors in India. J Cli Microbiol 41(4):1788–1790

    Article  Google Scholar 

  • Raimondo G, Allain JP, Brunetto MR et al (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:654–659

    Google Scholar 

  • Scheiblauer H, Soboll H, Nick S (2006) Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 78(1):S66–S70

    Article  CAS  PubMed  Google Scholar 

  • Shang G, Yan Y, Yang B et al (2009) Two HBV DNA+/HBsAg − blood donors identified by HBV NAT in Shenzhen. China Tran Apher Sci 41(1):3–7

    Article  Google Scholar 

  • Stramer SL (2007a) Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 131:702–707

    PubMed  Google Scholar 

  • Stramer SL (2007b) Current risks of transfusion-transmitted agents: a review. Archives of Path & Lab Med 131(5):702–707

    Google Scholar 

  • Tomono T, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY et al (2002) Status of NAT screening for HCV, HIV and HBV: experience in Japan. Dev Biol (Basel) 108:29–39

    CAS  Google Scholar 

  • Velati C, Fomiatti L, Baruffi L et al (2005) Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001–2003). Euro Surveill 10:2–14

    Google Scholar 

  • Wiedmann M, Kluwick S, Walter M et al (2007) HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors. J Clin Vir 39:282–287

    Article  CAS  Google Scholar 

  • World Health Organization (2009) Global blood safety and availability: facts and figures from the 2007 blood safety survey. Fact Sheet no. 279. WHO, Geneva

    Google Scholar 

  • World Health Organization (2010) Screening donated blood from transfusion transmissible infections: recommendations. WHO, Geneva

    Google Scholar 

  • Zekri AR, Awlia AA, El Mahalawi H, Ismail EF, Mabrouk GM (2002) Evaluation of blood units with isolated anti HBc for the presence of HBV DNA. Dis Markers 18(3):107–110

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Heba M. Selim, Mohamed A. ElBashaar & Sahar G. ElWakil

  2. Saudi German Hospital, Jeddah, Saudi Arabia

    Heba M. Selim, Mohamed A. ElBashaar & Sahar G. ElWakil

Authors
  1. Heba M. Selim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed A. ElBashaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sahar G. ElWakil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamed A. ElBashaar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Selim, H.M., ElBashaar, M.A. & ElWakil, S.G. Donor minipool NAT screening for HBV, HCV, and HIV: a 2-year experience in a private hospital in Saudi Arabia. Comp Clin Pathol 23, 1125–1132 (2014). https://doi.org/10.1007/s00580-013-1751-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-013-1751-3

Keywords

Search

Navigation